|Articles|June 11, 2021
Analytical instrument portfolio for clinical diagnostics
Thermo Scientific’s Medical Device (MD) portfolio of liquid chromatography-mass spectrometry (LC–MS) systems comprises of United States Food and Drug Administration (U.S. FDA) Class I medical devices, including the Vanquish MD High Performance Liquid Chromatography (HPLC) system, TSQ Altis MD Series mass spectrometer and Quantis MD Series mass spectrometer. According to the company, the systems are designed to increase throughput of clinical diagnostic assays for the detection of small to large molecules within complex biological matrices.
Thermo Fisher Scientific, San Jose, CA
Trending on LCGC International
1
Chromatography's Role in Spotting False Leachables
2
Fast GC-MS/MS Detects PFAS in Food Packaging
3
AI/ML in Practice: Machine-learning Prediction of Chromatographic Retention Times for Small Molecules in Pharmaceutical Applications
4
Emerging Contaminants and the Shifting PFAS Landscape
5